7104-61-2Relevant articles and documents
Benzimidazole derivative as well as synthesis method and application thereof
-
, (2021/08/11)
The invention discloses a benzimidazole derivative as well as a synthesis method and application thereof, and relates to the technical field of antiviral therapeutic drugs. According to the benzimidazole derivative as well as the synthesis method and appl
Compound with anti-Lassa virus activity, and preparation method and application thereof
-
, (2021/08/07)
The invention discloses a compound with anti-Lassa virus activity, and a preparation method and application thereof, and relates to the technical field of antiviral therapeutic drugs. The compound is 2, 6-dimethoxy-4-((1-(4-methoxyphenyl)-1h-benzo[d]imida
Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole
Dai, Dongcheng,Burgeson, James R.,Gharaibeh, Dima N.,Moore, Amy L.,Larson, Ryan A.,Cerruti, Natasha R.,Amberg, Sean M.,Bolken, Tove C.,Hruby, Dennis E.
, p. 744 - 749 (2013/02/25)
A chemically diverse library of about 400,000 small molecules was screened for antiviral activity against lentiviral pseudotypes with the Lassa virus envelope glycoprotein (LASV GP) gene incorporated. High-throughput screening resulted in discovery of a h
SMALL MOLECULE COMPOUNDS FOR STEM CELL DIFFERENTIATION
-
Page/Page column 63; 64, (2010/04/25)
Methods and small molecule compounds for stem cell differentiation are provided. One example of a class of compounds that may be used is represented by the compound having the structure IA or IB in the form of free base or a pharmaceutically acceptable salt, hydrate, solvate or N-oxide thereof. R1 is independently hydrogen or (C1-C6)alkyl; R2 is independently hydrogen, (C1-C6)alkyl, aryl, or heteroaryl; R2' is independently hydrogen, (C1-C6)alkyl, CF3 or C2F5; R3 is independently (C1-C6)alkyl, aryl, 2-tetrahydrofuryhnethyl, an aliphatic tertiary amine, or 4-methoxybenzyl; or R2 and R3 may be joined together to form a 5 or 6 member ring lactone; R4 is independently hydrogen, (C1-C6)alkyl, a 2- or 4-R5-substituted aromatic ring selected from a 4-R5-phenyl or a 2-R5-5-pyridyl, aryl, heteroaryl, aliphatic tertiary amine or halogen; and R5, R5', R6, R6', R7, R7' are each independently hydrogen, (C1-C6)alkyl, aryl, optionally substituted phenyl, heteroaryl, a heterocyclic ring, an aliphatic tertiary amine, or halogen.